Shitara, Kohei
Xu, Rui-Hua
Ajani, Jaffer A.
Moran, Diarmuid
Guerrero, Abraham
Li, Ran
Pavese, Janet
Matsangou, Maria
Bhattacharya, Pranob
Ueno, Yoko
Wang, Xuewei
Shah, Manish A. http://orcid.org/0000-0002-6913-9655
Funding for this research was provided by:
Astellas Pharma Inc.
Article History
Received: 29 January 2024
Accepted: 26 May 2024
First Online: 2 July 2024
Declarations
:
: K. Shitara received grants for institutional research or contracts from Astellas Pharma Inc., Ono Pharmaceutical, Daiichi Sankyo, Taiho Pharmaceutical, Chugai Pharma, MSD, Amgen, Eisai, and Medi Science; received consulting fees from or served in advisory roles for Eli Lily and Company, Bristol Myers Squibb, Takeda Pharmaceuticals, Pfizer Inc, Ono Pharmaceutical, Novartis, AbbVie Inc, Daiichi Sankyo, Taiho Pharmaceutical, GlaxoSmithKline, Amgen, Boehringer Ingelheim, MSD, Guardant Health Japan, and Janssen; and received honoraria from Bristol Myers Squibb, Takeda Pharmaceuticals, and Janssen. J.A. Ajani received grants for institutional research from Turning Point, Bristol Myers Squibb, Merck, Astellas Pharma Inc., Taiho Pharmaceutical, Delta-Fly, Roche, Prolinx, Zymeworks, Daiichi Sankyo, Leap, Gilead, and LaNova; consulting fees and honoraria from Bristol Myers Squibb, Merck, Astellas Pharma Inc., Amgen, Taiho Pharmaceuticals, Zymeworks, BeiGene, AstraZeneca, Daiichi Sankyo, Bayer, Grail, Novartis, Geneos, Servier Laboratories, and Gilead; support for attending meetings or travel from Daiichi Sankyo, Bristol Myers Squibb, and Merck; and served in an advisory role for BeiGene. D. Moran, A. Guerrero, R. Li, J. Pavese, M. Matsangou, P. Bhattacharya, Y. Ueno, and X. Wang are full-time employees of Astellas Pharma Inc. M.A. Shah received grants for institutional research from Merck, Bristol Myers Squibb, and Oncolys Biopharma; and served in an advisory role on the ASCO Leadership Council. All authors received study funding and support for medical writing and editing from Astellas Pharma Inc.